Degenerative mitral regurgitation is a major threat to public health and affects at least 24
million people worldwide, with an estimated 0.88 million disability-adjusted life years and …

Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in
patients with MVP, involving two phases based on the clinical and imaging context and the …

In patients with aortic and/or mitral valve disease the presence of pulmonary hypertension
(PH) indicates a decompensated state of the disease with left ventricular and left atrial …

Background Transcatheter mitral valve replacement (TMVR) is feasible for selected patients
with severe mitral regurgitation (MR) who are poor candidates for valve surgery …

Mitral regurgitation (MR) is a complex valve lesion that can pose significant management
challenges. This expert consensus decision pathway emphasizes that recognition of MR …

Background: Mitral valve (MV) repair is preferred over replacement in clinical guidelines and
is an important determinant of the indication for surgery in degenerative mitral regurgitation …

Background: Symptomatic mitral regurgitation (MR) is associated with high morbidity and
mortality that can be ameliorated by surgical valve repair or replacement. Despite this, many …

Background: Transcatheter mitral valve replacement (TMVR) is a rapidly evolving therapy.
Follow-up of TMVR patients remains limited in duration and number treated. Objectives: The …

Mitral regurgitation (MR) is a complex valve lesion that can pose significant management
challenges for the cardiovascular clinician. This Expert Consensus Document emphasizes …

Background: Echocardiographic quantitation of degenerative mitral regurgitation (DMR) is
recommended whenever possible in clinical guidelines but is criticized and its scalability to …